Epilepsy and Behavior

Journal

Publication Venue For

  • Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy.  111. 2020
  • Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists.  109. 2020
  • Poverty, insurance, and region as predictors of epilepsy treatment among US adults.  107. 2020
  • Language predictors of autism spectrum disorder in young children with tuberous sclerosis complex.  103. 2020
  • Optimizing therapies for neurobehavioral comorbidities of epilepsy using chronic ambulatory electrocorticography.  102. 2020
  • Racial differences in adult-onset MRI-negative temporal lobe epilepsy.  100. 2019
  • Health literacy and quality of life in patients with treatment-resistant epilepsy.  99. 2019
  • Drug–drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program.  98:201-206. 2019
  • Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsy.  97:105-110. 2019
  • A pilot study of combined endurance and resistance exercise rehabilitation for verbal memory and functional connectivity improvement in epilepsy.  96:44-56. 2019
  • fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy.  96:114-121. 2019
  • Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiol.  95:131-136. 2019
  • Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy.  95:10-17. 2019
  • Driving status of patients with generalized spike–wave on EEG but no clinical seizures.  92:5-13. 2019
  • Cortical excitability affects mood state in patients with idiopathic generalized epilepsies (IGEs).  90:84-89. 2019
  • Cortical excitability and seizure control influence attention performance in patients with idiopathic generalized epilepsies (IGEs).  89:135-142. 2018
  • Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study.  87:131-136. 2018
  • Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes.  86:131-137. 2018
  • Affiliate stigma and caregiver burden in intractable epilepsy.  85:1-6. 2018
  • Facial emotion processing in patients with seizure disorders.  79:193-204. 2018
  • The clinical impact of integration of magnetoencephalography in the presurgical workup for refractory nonlesional epilepsy.  79:34-41. 2018
  • Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study Pongkiat Kankirawatana, Dr Rani Singh, Professor David G Standaert, Dr Yuliang Liu, Dr Leon Dure, Dr Jennifer DeWollfe, Professor Gary Cutter, Dr Tyler Gaston, Dr Ashley Thomas, Professor E. Martina Bebin, Dr. Lawrence Ver Hoef.  (in press). 2018
  • Orbitofrontal epilepsy: Case series and review of literature.  76:32-38. 2017
  • Post-traumatic epilepsy associations with mental health outcomes in the first two years after moderate to severe TBI: A TBI Model Systems analysis.  73:240-246. 2017
  • Precuneal epilepsy: Clinical features and surgical outcome.  73:77-82. 2017
  • Increased odds and predictive rates of MMPI-2-RF scale elevations in patients with psychogenic non-epileptic seizures and observed sex differences.  72:43-50. 2017
  • Cannabinoids and epilepsy — Introduction.  70:277. 2017
  • Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.  70:349-354. 2017
  • Pharmacology of cannabinoids in the treatment of epilepsy.  70:313-318. 2017
  • Quality Indicator for Epilepsy Treatment 15 (QUIET-15): Intervening after recurrent seizures in the elderly.  70:253-258. 2017
  • Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsy.  70:364-369. 2017
  • Social factors in marijuana use for medical and recreational purposes.  70:280-287. 2017
  • Photosensitivity in generalized epilepsies.  68:225-233. 2017
  • Adherence to antiepileptic drugs among diverse older Americans on Part D Medicare.  66:68-73. 2017
  • Which patients with epilepsy are at risk for psychogenic nonepileptic seizures (PNES)? A multicenter case–control study.  61:180-184. 2016
  • Parent health literacy and adherence-related outcomes in children with epilepsy.  56:73-82. 2016
  • Assessment of driving outcomes after epilepsy surgery.  52:25-30. 2015
  • Personalities of patients with nonepileptic psychogenic status.  52:143-148. 2015
  • New-onset refractory status epilepticus (NORSE) - The potential role for immunotherapy.  47:17-23. 2015
  • The effect of medial temporal lobe epilepsy on visual memory encoding.  46:173-184. 2015
  • Uncinate fasciculus connectivity in patients with psychogenic nonepileptic seizures: A preliminary diffusion tensor tractography study.  45:68-73. 2015
  • Cannabis, cannabidiol, and epilepsy - From receptors to clinical response.  41:277-282. 2014
  • Physiologic and cortical response to acute psychosocial stress in left temporal lobe epilepsy: Response to a biochemical evaluation.  41:312-313. 2014
  • Social determinants of health in epilepsy.  41:283-289. 2014
  • Celebrating 15years of Epilepsy & Behavior and to the next 15years!.  40:77. 2014
  • Functional MRI of facial emotion processing in left temporal lobe epilepsy.  32:92-99. 2014
  • Contributions of fMRI towards our understanding of the response to psychosocial stress in epilepsy and psychogenic nonepileptic seizures.  35:19-25. 2014
  • Different localizations underlying cortical gelastic epilepsy: Case series and review of literature.  35:34-41. 2014
  • EEG/fMRI contributions to our understanding of genetic generalized epilepsies.  34:129-135. 2014
  • How focal is generalized epilepsy: A distinction with a difference?.  34:127-128. 2014
  • Physiologic and cortical response to acute psychosocial stress in left temporal lobe epilepsy - A pilot cross-sectional fMRI study.  36:115-123. 2014
  • Art and epilepsy surgery.  29:82-89. 2013
  • The effects of temporal lobe epilepsy on scene encoding.  26:11-21. 2013
  • Differential effects of antiepileptic drugs on neonatal outcomes.  24:449-456. 2012
  • Topiramate and its effect on fMRI of language in patients with right or left temporal lobe epilepsy.  24:74-80. 2012
  • Systematic review and case series of neuropsychological functioning after epilepsy surgery in children with dysembryoplastic neuroepithelial tumors (DNET).  23:481-486. 2012
  • Initial EEG predicts outcomes in a trial of levetiracetam vs. fosphenytoin for seizure prevention.  23:280-284. 2012
  • Geriatric epilepsy: Research and clinical directions for the future.  22:103-111. 2011
  • Corrigendum to "Planning extent of resection in epilepsy: Limited versus large resections" [Epilepsy & Behavior 20, Issue 2 (2011) 233-240].  21:494. 2011
  • Semantic association investigated with functional MRI and independent component analysis.  20:613-622. 2011
  • The effects of left or right hemispheric epilepsy on language networks investigated with semantic decision fMRI task and independent component analysis.  20:623-632. 2011
  • Planning extent of resection in epilepsy: Limited versus large resections.  20:233-240. 2011
  • Nonepileptic psychogenic status: Markedly prolonged psychogenic nonepileptic seizures.  19:65-68. 2010
  • Cortical and subcortical contributions to absence seizure onset examined with EEG/fMRI.  18:404-413. 2010
  • Moderating effect of optimism on emotional distress and seizure control in adults with temporal lobe epilepsy.  18:374-380. 2010
  • Passive real-time identification of speech and motor cortex during an awake craniotomy.  18:123-128. 2010
  • Seizure control in patients with idiopathic generalized epilepsies: EEG determinants of medication response.  17:525-530. 2010
  • The effect of seizures on working memory and executive functioning performance.  17:412-419. 2010
  • Application of signal detection theory to verbal memory testing to distinguish patients with psychogenic nonepileptic seizures from patients with epileptic seizures.  14:597-603. 2009
  • Compensatory brain activation for recognition memory in patients with medication-resistant epilepsy.  13:463-469. 2008
  • Optimism, pessimism, and neuropsychological performance across semiology-based subtypes of psychogenic nonepileptic seizures.  13:478-484. 2008
  • The safety and tolerability of galantamine in patients with epilepsy and memory difficulties.  13:376-380. 2008
  • Rey Osterrieth complex figure test spatial and figural scoring: Relations to seizure focus and hippocampal pathology in patients with temporal lobe epilepsy.  13:174-177. 2008
  • The use of self-generation procedures facilitates verbal memory in individuals with seizure disorders.  13:162-168. 2008
  • Medial temporal fMRI activation reflects memory lateralization and memory performance in patients with epilepsy.  12:410-418. 2008
  • Chronic isolated hemifacial spasm as a manifestation of epilepsia partialis continua.  12:332-336. 2008
  • Comprehensive presurgical functional MRI language evaluation in adult patients with epilepsy.  12:74-83. 2008
  • A psychosocial self-management program for epilepsy: A randomized pilot study in adults.  11:533-545. 2007
  • Relationship between semiology of psychogenic nonepileptic seizures and Minnesota Multiphasic Personality Inventory profile.  11:105-111. 2007
  • Structural and functional neuroimaging correlates of depression in temporal lobe epilepsy.  10:242-249. 2007
  • A comparison of physicians' attitudes and beliefs regarding driving for persons with epilepsy.  10:55-62. 2007
  • Medical decision-making abilities in older adults with chronic partial epilepsy.  10:63-68. 2007
  • The effects of duration of intractable epilepsy on memory function.  9:469-477. 2006
  • Racial/ethnic disparities in the treatment of epilepsy: What do we know? What do we need to know?.  9:243-264. 2006
  • Effect of vagus nerve stimulation on creativity and cognitive flexibility.  8:720-725. 2006
  • Nonepileptic seizures treatment workshop summary.  8:451-461. 2006
  • Quality of life in medication-resistant epilepsy: The effects of patient's age, age at seizure onset, and disease duration.  8:547-551. 2006
  • Determining empirically based self-reported cognitive change: Development of reliable change indices and standardized regression-based change norms for the multiple abilities self-report questionnaire in an epilepsy sample.  8:239-245. 2006
  • Older adults with epilepsy demonstrate cognitive impairments compared with patients with amnestic mild cognitive impairment.  8:161-168. 2006
  • Development of reliable change indices and standardized regression-based change norms for the Multiple Abilities Self-report Questionnaire (MASQ) in an epilepsy sample.  8:239-245. 2006
  • Race/ethnicity: A predictor of temporal lobe epilepsy surgery outcome?.  7:486-490. 2005
  • Measuring depressive symptoms among treatment-resistant seizure disorder patients: POMS Depression scale as an alternative to the BDI-II.  7:266-272. 2005
  • Measuring depressive symptoms among treatment-resistant seizure disorder patients: POMS Depression scale as an alternative to the BDI-II..  7:266-272. 2005
  • What are the concerns of older adults living with epilepsy?.  7:297-300. 2005
  • What are the concerns of older adults living with epilepsy?.  7:297-300. 2005
  • Verbal memory outcome in patients with normal preoperative verbal memory and left mesial temporal sclerosis.  6:337-341. 2005
  • Effects of zonisamide on the electroencephalogram of a patient with juvenile myoclonic epilepsy.  5:1024-1026. 2004
  • Reporting race/ethnicity in epilepsy clinical trials.  5:743-745. 2004
  • Self-report of cognitive abilities in temporal lobe epilepsy: Cognitive, psychosocial, and emotional factors.  5:575-579. 2004
  • Taking charge of epilepsy: The development of a structured psychoeducational group intervention for adolescents with epilepsy and their parents.  5:547-556. 2004
  • Seizure disorders, depression, and health-related quality of life.  5:50-57. 2004
  • Accuracy of self-reported neuropsychological functioning in individuals with epileptic or psychogenic nonepileptic seizures.  5:143-150. 2004
  • High-resolution functional MRI at 3 T in healthy and epilepsy subjects: Hippocampal activation with picture encoding task.  5:244-252. 2004
  • Health-related quality of life in senior adults with epilepsy: What we know from randomized clinical trials and suggestions for future research.  4:626-634. 2003
  • Ketamine for refractory status epilepticus : A case of possible ketamine-induced neurotoxicity.  4:70-75. 2003
  • Does the wada test predict memory decline following epilepsy surgery?.  3:4-15. 2002
  • Gender, memory, and hippocampal volumes: Relationships in temporal lobe epilepsy.  1:112-119. 2000
  • Nonlinear trends in hippocampal metabolic function and verbal memory: Evidence of cognitive reserve in temporal lobe epilepsy?.  1:106-111. 2000
  • International Standard Serial Number (issn)

  • 1525-5050
  • Electronic International Standard Serial Number (eissn)

  • 1525-5069